As always, thanks for the update BDAZ.

So the re-org is delayed...probably no surprise there. Just another false promise by Don.

Has anyone received an update on Don's "reverse takeover as a method to achieve a TSX listing and possibly a NASDAQ for Zenith?". Has he "talked to his accountant yet?" as per masila's notes.

I guess I really can't say what I am truly thinking on Agoracom so suffice it to say I have become extremely cynical about Zenith management. There is a reason why the "Blunt Bean Counter" posting comes up on the first page of Google searches continuously. Of course that accountant didn't seem to understand that biotech is extremely high risk.

The management group seems disorganized. They are not buttoned down at all. A high paid, competent management group would be on top of things!

At this stage I'm even beginning to wonder about the science. I've always been convinced that the science must be solid because of the scientific talent on the BoM steering committee, Eastern, NGN and Hepalink's investments, the very positive post hocs on rvx-208, etc. However, there has been no interest from big pharma...hence the need for Hepalink to step in. It is very concerning that BP has zero interest after 15 years of scientific development. BP must feel that Zenith/RVX are barking up the wrong tree.

Anyway, perhaps it is just the winter blahs but I must say I've become very concerned with the extremely poor performance by management and I am very sure that thousands of potential investors are very leary of Zenith and RVX. If a change was made at the top I believe there could be a dramatic movement forward at both companies.

Anyway...JMHO from an extremely frustrated (locked in) holder of Zenith shares. GLTA because we will really need it. Perhaps 2021 will pay off big.

Toinv